Physician profile
Hallie Mcnew
NPI 1487052874
$4,664.33
in general payments reported to CMS, 2019-2025
19 companies · $2,019 in 2025
The $2,019 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.61 · 2022: $952 · 2023: $830 · 2024: $785 · 2025: $2,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Travel and Lodging: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.19 |
| Travel and Lodging | $1,288.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,426.71 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Edwards Lifesciences Corporation | $1,362.02 | 2022-2025 | Hemosphere, Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Abiomed | $783.16 | 2021-2024 | Impella |
| Abbott Laboratories | $279.64 | 2021-2025 | Epic |
| Janssen Pharmaceuticals, INC | $129.21 | 2022-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $99.22 | 2024 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.18 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $84.68 | 2023 | Camzyos |
| Novo Nordisk INC | $81.70 | 2024 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $50.86 | 2023-2024 | Inpefa |
| Haemonetics Corporation | $50.78 | 2022-2025 | Teg6s Hemostasis System |
| Ethicon US, LLC | $43.73 | 2023 | Vistaseal |
| Pfizer INC. | $36.16 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.40 | 2021 | |
| Zimmer Biomet Holdings, INC. | $30.13 | 2024 | Myo/Wire, A&E Medical / Rotating Surgical Punches |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $25.54 | 2024 | Paradise Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $20.03 | 2024 | Arcalyst |
| Medtronic, INC. | $17.94 | 2023 | Azure Xt Dr Mri Surescan |
| Kci USA, INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hallie Mcnew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.